381 / 1708
CCG/RTOG
•
233 pts randomized to 35-40 Gy CSRT, 50-55 Gy PFRT +/-
VCR, CCNU, prednisone x 1 year
•
No difference in survival
•
Benefit in those receiving chemotherapy with T3, T4 or M+
disease
Evans AE et al. J Neurosurg 1990; 72:572-82